Zikani Therapeutics is a new anti-infective company founded to advance groundbreaking technology. Founded by Andrew G. Myers and Lawrence G. Miller in 2014, Zikani Therapeutics is backed by investors that include Advent Life Sciences, Gurnet Point Capital, and Roche Venture Fund and is headquartered in Newton.
FOUNDED:
2014
INDUSTRY:
Biotechnology, Life Science, Pharmaceutical
FOUNDERS:
Andrew G. Myers, Lawrence G. Miller
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
